Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Bullous impetigo is a contagious superficial infection occurring in intact skin. Prevalence in the general population is unknown. The disease is characterized by fragile vesicles and flaccid blisters, most often presenting as erosive lesions covered by a yellow crust. The face, trunk and extremities of children under 5 years of age (particularly neonates) are mainly affected. The disease is generally caused by group II Staphylococcus aureus.
Features include very common findings: Recurrent bacterial skin infections, Abnormal blistering of the skin, Erythema, and Pustule; and sometimes findings: Septic arthritis, Abnormality of the lymphatic system, Sepsis, and Kidney filtering unit damage (glomerulopathy).
Organ System | Phenotype Count | Example Features |
|---|---|---|
Skin | 3 | Recurrent bacterial skin infections, Abnormal blistering of the skin, Erythema |
Biomarker and diagnostic research for bullous impetigo has been reported in the published literature.
Phenotype severity distribution: 4 very common features.
Estimated prevalence: Unknown (Unknown prevalence).
No clinical trials have been registered for bullous impetigo.
14 publications have been identified in PubMed for bullous impetigo. Research spans Case Report / Case Series (62%), Review / Meta-Analysis (15%), and Diagnostic / Biomarker (8%).
Research Type | Count | % of Total |
|---|---|---|
Patient case studies | 8 | 62% |
Data assembled from 4 of 12 sources · Last updated Sep 19, 2026, 2:45 AM UTC
European rare disease database
Genetic and Rare Diseases Info Center
Bones and joints |
1 |
Septic arthritis |
Blood and immune system | 1 | Recurrent bacterial skin infections |
Kidneys and urinary system | 1 | Kidney filtering unit damage (glomerulopathy) |
2 |
15% |
Testing and diagnosis research | 1 | 8% |
Clinical study results | 1 | 8% |
New treatment approaches | 1 | 8% |
Trang DT (2026). [PMID: 41839109](https://pubmed.ncbi.nlm.nih.gov/41839109/). *American family physician*. [Clinical Trial Publication]
Sila Yuksel S (2026). [PMID: 41780601](https://pubmed.ncbi.nlm.nih.gov/41780601/). *Journal of the American Academy of Dermatology*. [Gene Therapy / Novel Therapeutics]
Naqvi A (2026). [PMID: 41833263](https://pubmed.ncbi.nlm.nih.gov/41833263/). *The Journal of emergency medicine*. [Case Report / Case Series]
Kaufman LC (2026). [PMID: 41480868](https://pubmed.ncbi.nlm.nih.gov/41480868/). *Pediatric annals*. [Review / Meta-Analysis]
Chan CJ (2026). [PMID: 41934221](https://pubmed.ncbi.nlm.nih.gov/41934221/). *J Paediatr Child Health*. [Case Report / Case Series]
Martínez Ortega JI (2026). [PMID: 41411693](https://pubmed.ncbi.nlm.nih.gov/41411693/). *Semergen*. [Case Report / Case Series]
Altaho N (2025). [PMID: 41552107](https://pubmed.ncbi.nlm.nih.gov/41552107/). *Cureus*. [Case Report / Case Series]
Palanimuthu D (2025). [PMID: 39968434](https://pubmed.ncbi.nlm.nih.gov/39968434/). *Cureus*. [Case Report / Case Series]
Novoa-Moreno AL (2025). [PMID: 40559203](https://pubmed.ncbi.nlm.nih.gov/40559203/). *Infectious disease reports*. [Case Report / Case Series]
Arunima A (2025). [PMID: 41395646](https://pubmed.ncbi.nlm.nih.gov/41395646/). *The British journal of dermatology*. [Diagnostic / Biomarker]